CClinicalTrials.gg
CompletedNCT02768233Updated Jan 4, 2023

Medication-overuse Headache: The Effect of a Patient Educational Programme as an add-on to Standard Treatment

An interventional study of Educational programme in Secondary Headache Disorders and Medication-overuse Headache, sponsored by Esbjerg Hospital - University Hospital of Southern Denmark. Completed. Open to participants aged 18 Years to 65 Years. Per ClinicalTrials.gov, last updated 2023-01-04.

Sponsored by Esbjerg Hospital - University Hospital of Southern Denmark · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 6 months after the study started (first participant enrolled Oct 2015, registered May 2016).
Phase
Not applicable
Study type
Interventional
Enrollment
98
Allocation
Randomized
Ages
18 Years to 65 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the influence of personality profiles in patients with MOH and to evaluate the effect of a custom-made educational programme as an add-on to standard treatment as compared to standard treatment alone in MOH patients using a randomized controlled trial (RCT) design.

Read the detailed description

Worldwide, two percent of the population suffers from medication-overuse headache (MOH), a paradox condition where the headache is caused by overuse of headache medication. Common treatment is withdrawal, but there is no consensus on what constitutes the best treatment.

The study consists of a RCT with MOH patients randomized to standard treatment versus standard treatment + a 12-week, 6-session educational programme as add-on. The programme is based on theory of motivational interviewing, and patients can choose between individualized education or education in groups.

Primary endpoint: Headache frequency measured by self-reported headache diary on number of days with headache pre-vious month. Secondary endpoints: NEO-FFI-3 personality test, coping strategies, pain intensity, bothersomeness, patient satis-faction and reported medication intake.

02

Conditions studied

  • Secondary Headache Disorders
  • Medication-overuse Headache

Keywords

  • Medication-overuse Headache
  • Educational Programme
  • Personality Profiles
03

In context

Headache Disorders

162 studies on the registry are indexed under Headache Disorders; 40 are open to participants now.

This study's enrollment of 98 is above the median of 60 across 103 interventional studies indexed under Headache Disorders.

Browse Headache Disorders studies →

Lead sponsor

Esbjerg Hospital - University Hospital of Southern Denmark is the lead sponsor of 45 studies on the registry; 16 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 65 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Diagnosed with medication-overuse headache (MOH) by neurologist (The International Classification of headache Disorders).
  • Completed withdrawal (hospitalized of 8 days or at home).
  • Age 18-65 years
  • Understand and speak Danish

Exclusion criteria

Exclusion Criteria:

  • Comorbidity (e.g. whiplash, rheumatism which needs analgesic treatment
  • Mental health disorders
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Investigator)
Enrollment
98 participants (actual)

Study arms

  • Experimental
    Educational programme

    Group 1: Educational programme + standard treatment

    Behavioral: Educational programme

  • No intervention
    Standard treatment

    Standard treatment

Interventions

  • BehavioralEducational programme

    The 6-session educational programme is based on theory of motivational interviewing, and patients can choose between individualized education or education in groups. The standard treatment consists of withdrawal and consultations by neurologist.

06

What researchers measure

Primary outcomes

  1. Headache frequency measured by self-reported headache diary on number of days with headache previous month

    Time frame: baseline-36 weeks follow-up

Secondary outcomes

  1. NEO-FFI-3 personality test

    self reported. 63 items. Each item scores using a 5 point Likert scale ranging from 1 (strongly disagree) to 5 (strongly agree)

    Time frame: Baseline

  2. Coping Strategies

    CSQ Questionnaire (Scale ranging from 0 (never) to 6 (always)

    Time frame: Baseline, Post intervention (16 weeks), Follow-up (36 weeks)

  3. Pain Intensity

    VAS (0: No pain, 10: Pain as bad as it can be)

    Time frame: Baseline, Post intervention (16 weeks), Follow-up (36 weeks)

  4. Bothersomeness

    VAS (0: No bothersomeness, 10: Bothersomeness as bad as it can be)

    Time frame: Baseline, Post intervention (16 weeks), Follow-up (36 weeks)

  5. Patient satisfaction

    Questionnarire

    Time frame: Baseline, Post intervention (16 weeks), Follow-up (36 weeks)

  6. Medication intake

    self reported intake (type, name of medication, dosis)

    Time frame: baseline, Post intervention (16 weeks) and Follow-up (36 weeks)

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Mose LS, Pedersen SS, Jensen RH, Gram B. Medication-overuse headache: The effect of a patient educational programme-A randomized controlled trial. Eur J Pain. 2020 Feb;24(2):435-447. doi: 10.1002/ejp.1500. Epub 2019 Nov 21. PubMed 31661579 ↗

Individual participant data

Plan to share: No

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 4, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02768233
Lead sponsor
Esbjerg Hospital - University Hospital of Southern Denmark
Responsible party
Louise Schlosser Mose (PhD student, Esbjerg Hospital - University Hospital of Southern Denmark) — Principal investigator
First posted
May 11, 2016
Start date
Oct 15, 2015
Primary completion
Jul 1, 2018
Completion
Jan 2019
Last update
Jan 4, 2023

Study contacts

Louise S. Mose, MHS
principal investigator · Hospital of South West Jutland, Denmark

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion